{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:28:22Z","timestamp":1790389702218,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA150300"],"award-info":[{"award-number":["CA150300"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00720","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T10:06:31Z","timestamp":1564740391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models"],"prefix":"10.3389","volume":"9","author":[{"given":"Peter R.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukun W.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Premeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Soprana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Panigada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen M.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Hindocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Menor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedbar S.","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenny","family":"Moise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishomwa C.","family":"Ndhlovu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Siccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"De Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Bertino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13148-018-0517-9","article-title":"Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma","volume":"10","author":"Bensaid","year":"2018","journal-title":"Clin Epigenetics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2018.09.009","article-title":"Immunoengineering through cancer vaccines\u2013a personalized and multi-step vaccine approach towards precise cancer immunity","volume":"289","author":"Lybaert","year":"2018","journal-title":"J Control Release"},{"key":"B3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fonc.2018.00315","article-title":"Immuno-oncology: emerging targets and combination therapies","volume":"8","author":"Marshall","year":"2018","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/vaccines6030052","article-title":"Next generation cancer vaccines-make it personal!","volume":"6","author":"Terbuch","year":"2018","journal-title":"Vaccines."},{"key":"B5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fmicb.2014.00502","article-title":"Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection","volume":"5","author":"Moise","year":"2014","journal-title":"Front Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1080\/21645515.2015.1061159","article-title":"iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines","volume":"11","author":"Moise","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1586\/14760584.2016.1123098","article-title":"T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity","volume":"15","author":"Moise","year":"2016","journal-title":"Expert Rev Vaccines."},{"key":"B8","doi-asserted-by":"publisher","first-page":"197ra103","DOI":"10.1126\/scitranslmed.3006034","article-title":"Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells","volume":"5","author":"Cameron","year":"2013","journal-title":"Sci Transl Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Morgan","year":"2013","journal-title":"J Immunother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1182\/blood-2007-01-070748","article-title":"OX40 costimulation turns off Foxp3+ Tregs","volume":"110","author":"Vu","year":"2007","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.4049\/jimmunol.181.5.3193","article-title":"OX40\/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo","volume":"181","author":"Xiao","year":"2008","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3892\/mmr_00000146","article-title":"Pre-treatment with cyclophosphamide or OX40 (CD134) costimulation targeting regulatory T cell function enhances the anti-tumor immune effect of adoptively transferred CD8+ T cells from wild-type mice","volume":"2","author":"Ueki","year":"2009","journal-title":"Mol Med Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e27297","DOI":"10.4161\/onci.27297","article-title":"Trial watch: immunostimulatory monoclonal antibodies in cancer therapy","volume":"3","author":"Aranda","year":"2014","journal-title":"Oncoimmunology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ijc.2910520609","article-title":"Establishment of a murine model of malignant mesothelioma","volume":"52","author":"Davis","year":"1992","journal-title":"Int J Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/ijc.28048","article-title":"Fowlpox-based survivin vaccination for malignant mesothelioma therapy","volume":"133","author":"Bertino","year":"2013","journal-title":"Int J Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1078\/0344-0338-00427","article-title":"Culturing mouse peritoneal mesothelial cells","volume":"199","author":"Bot","year":"2003","journal-title":"Pathol Res Pract"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1074\/mcp.M112.024919","article-title":"Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse","volume":"12","author":"Geiger","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"170112","DOI":"10.1038\/sdata.2017.112","article-title":"FANTOM5 CAGE profiles of human and mouse samples","volume":"4","author":"Noguchi","year":"2017","journal-title":"Sci Data"},{"key":"B19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.celrep.2018.06.052","article-title":"OX40 costimulation inhibits Foxp3 expression and treg induction via BATF3-dependent and independent mechanisms","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/eji.200939493","article-title":"CpG-enhanced CD8+ T-cell responses to peptide immunization are severely inhibited by B cells","volume":"40","author":"Overstreet","year":"2010","journal-title":"Eur J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e27364","DOI":"10.7554\/eLife.27364","article-title":"Immunoproteasome functions explained by divergence in cleavage specificity and regulation","volume":"6","author":"Winter","year":"2017","journal-title":"Elife"},{"key":"B22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00251-018-1082-2","article-title":"Genetics of antigen processing and presentation","volume":"71","author":"Kelly","year":"2018","journal-title":"Immunogenetics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2217\/mmt-2017-0021","article-title":"An update on the relevance of vaccine research for the treatment of metastatic melanoma","volume":"4","author":"Dillman","year":"2017","journal-title":"Melanoma Manag."},{"key":"B24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1084\/jem.172.3.947","article-title":"An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells","volume":"172","author":"Jaraquemada","year":"1990","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/343074a0","article-title":"Class II MHC molecules can use the endogenous pathway of antigen presentation","volume":"343","author":"Nuchtern","year":"1990","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1080\/21645515.2015.1050572","article-title":"Preclinical development of HIvax: human survivin highly immunogenic vaccines","volume":"11","author":"Hoffmann","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1126\/science.aau3879","article-title":"Somatic mutant clones colonize the human esophagus with age","volume":"362","author":"Martincorena","year":"2018","journal-title":"Science."},{"key":"B28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/PPO.0000000000000185","article-title":"Immune checkpoint therapy and the search for predictive biomarkers","volume":"22","author":"Sharma","year":"2016","journal-title":"Cancer J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2017.136","article-title":"Hallmarks of response to immune checkpoint blockade","volume":"117","author":"Cogdill","year":"2017","journal-title":"Br J Cancer."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.27188","article-title":"Human OX40 tunes the function of regulatory T cells in tumor and non-tumor areas of hepatitis C virus-infected liver tissue","volume":"60","author":"Piconese","year":"2014","journal-title":"Hepatology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1404214","DOI":"10.1080\/2162402X.2017.1404214","article-title":"OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis","volume":"7","author":"Xie","year":"2018","journal-title":"Oncoimmunology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.3892\/ol.2017.6805","article-title":"Identification of tumor antigens in malignant mesothelioma","volume":"14","author":"Kim","year":"2017","journal-title":"Oncol Lett"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S369","DOI":"10.21037\/jtd.2017.10.158","article-title":"Overexpressed genes in malignant pleural mesothelioma: implications in clinical management","volume":"10","author":"Barone","year":"2018","journal-title":"J Thorac Dis"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00720\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T09:46:16Z","timestamp":1569145576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00720\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":33,"alternative-id":["10.3389\/fonc.2019.00720"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00720","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"article-number":"720"}}